Literature DB >> 9463742

Lipoprotein(a) changes during and after coronary artery bypass grafting: an epiphenomenon?

C Cobbaert1, A Louisa, L Struijk, R Demeyere, B Meyns.   

Abstract

The lipoprotein(a) (Lp(a)) time course during and after coronary artery bypass grafting was examined in 20 caucasoid patients, in relation to the time courses of serum cholesterol and serum triglycerides. Samples were taken at eight different time points. Baseline geometric means (SD) for Lp(a), cholesterol and triglycerides were 115 (336) mg/L, 5.73 (1.10) mmol/L and 1.73 (1.21) mmol/L, respectively. Up to 10 min after cardiopulmonary bypass (CPB) and after correction for haemodilution, no observable effect of CPB on serum concentrations of Lp(a) could be demonstrated, whereas serum concentrations of total cholesterol and triglycerides showed a progressive and significant decline. Ten minutes after stopping CPB geometric means for cholesterol and triglyceride were 3.90 (0.82) and 0.90 (0.58) mmol/L, respectively. At the third post-operative day geometric Lp(a) and cholesterol means decreased to 62(90) mg/L and 2.97 (0.84) mmol/L, respectively, while triglycerides went up. It is concluded that Lp(a) levels remain constant during CPB, but mimic total cholesterol changes in the post-CABG period.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9463742     DOI: 10.1177/000456329803500109

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  2 in total

1.  Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk.

Authors:  D J Byrne; I A Jagroop; H E Montgomery; M Thomas; D P Mikhailidis; N G Milton; A F Winder
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

2.  Impact of Lipoprotein(a) Levels on Perioperative Outcomes in Cardiac Surgery.

Authors:  Paul Philipp Heinisch; Maks Mihalj; Markus Huber; Joerg C Schefold; Alexander Hartmann; Michael Walter; Elisabeth Steinhagen-Thiessen; Juerg Schmidli; Frank Stüber; Lorenz Räber; Markus M Luedi
Journal:  Cells       Date:  2021-10-21       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.